BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18602168)

  • 1. Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma.
    Dikkers FG
    Int J Pediatr Otorhinolaryngol; 2008 Oct; 72(10):1581-2; author reply 1583. PubMed ID: 18602168
    [No Abstract]   [Full Text] [Related]  

  • 2. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis.
    Broekema FI; Dikkers FG
    Eur Arch Otorhinolaryngol; 2008 Aug; 265(8):871-9. PubMed ID: 18458927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Preuss SF; Quante G
    Laryngoscope; 2010 Mar; 120(3):650; author reply 651. PubMed ID: 20013845
    [No Abstract]   [Full Text] [Related]  

  • 4. Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective.
    Tanna N; Sidell D; Joshi AS; Bielamowicz SA
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):497-500. PubMed ID: 18490570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Lott DG; Krakovitz PR
    Laryngoscope; 2009 Mar; 119(3):567-70. PubMed ID: 19235765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir and the black box warning.
    Inglis AF
    Ann Otol Rhinol Laryngol; 2005 Nov; 114(11):834-5. PubMed ID: 16358602
    [No Abstract]   [Full Text] [Related]  

  • 8. Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.
    Orssaud C; Wermert D; Roux A; Laccourreye O; Sors H; Roche O; Dufier JL
    Eye (Lond); 2014 Jun; 28(6):776-7. PubMed ID: 24675584
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyrohyoid approach to cidofovir injection: a case study.
    Getz AE; Scharf J; Amin MR
    J Voice; 2005 Sep; 19(3):501-3. PubMed ID: 16102676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR12/339--Nebulized cidofovir for recurrent respiratory papillomatosis: a case report.
    Giles BL; Seifert B
    Paediatr Respir Rev; 2006; 7 Suppl 1():S330. PubMed ID: 17036412
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
    Co J; Woo P
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection.
    Man LX; Statham MM; Rosen CA
    Ann Otol Rhinol Laryngol; 2010 Apr; 119(4):236-8. PubMed ID: 20433022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
    Chung BJ; Akst LM; Koltai PJ
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
    Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
    Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of local application of cidofovir on the control of recurrences in recurrent laryngeal papillomatosis.
    Pontes P; Avelino M; Pignatari S; Weckx LL
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):22-7. PubMed ID: 16815177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis.
    Wemer RD; Lee JH; Hoffman HT; Robinson RA; Smith RJ
    Ann Otol Rhinol Laryngol; 2005 Nov; 114(11):836-9. PubMed ID: 16358603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Office-based intralesional cidofovir injections for nasal septal papilloma: a pilot study.
    Shemen LJ; Shnayder Y
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):149-51. PubMed ID: 16815201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The schedule of intralesional papillomatosis treatment with cidofovir].
    Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
    Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
    Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
    J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
    Sheahan P; Sexton S; Russell JD
    J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.